NCT03506048 2022-11-10Lenvatinib and Iodine Therapy in Treating Patients With Radioactive Iodine-Sensitive Differentiated Thyroid CancerEmory UniversityPhase 2 Terminated4 enrolled 5 charts
NCT03630120 2021-07-14Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid CancerH. Lee Moffitt Cancer Center and Research InstitutePhase 2 Terminated6 enrolled 9 charts